The U.S. Department of Veterans Affairs has awarded a three-year contract to the American College of Radiology to serve as the accrediting organization for 33 VA hospital radiation oncology facilities across the country.
The U.S. Department of Veterans Affairs has awarded a three-year contract to the American College of Radiology to serve as the accrediting organization for 33 VA hospital radiation oncology facilities across the country.
The purpose of accreditation is to set quality practice standards and certify facilities that meet them, according to Dr. Harvey Neiman, ACR executive director. The peer-reviewed assessments include an evaluation of personnel qualifications, equipment performance, and image quality, as well as standards and protocols for quality assurance and quality control.
"The ACR is extremely proud to do its part to help ensure that our nation's veterans receive the highest quality healthcare available," Neiman said.
The college brings considerable experience to the assignment. About 200 radiation oncology facilities in the U.S. have either been accredited or are going through the ACR accreditation process. As with nongovernment facilities, the accreditation process for the VA services will involve both self-assessment and independent external expert audits, based on ACR guidelines and technical standards.
ACR accreditation requires that the physicians providing radiation therapy to patients meet specific education and training standards. It also mandates that the equipment be inspected regularly by qualified medical physicists and that the radiation therapists administering the treatments be appropriately certified.
In addition to radiation oncology, the ACR manages accreditation programs for MRI, CT, nuclear medicine, PET, diagnostic ultrasound, radiation oncology, stereotactic breast biopsy, mammography, and breast ultrasound. About 16,000 facilities have earned ACR accreditation, Neiman said.
For more information from the Diagnostic Imaging archives:
Proponents hail pass of Medicare bill as triumph for physicians, patients
FDA panel recommends adding stereotactic breast biopsy to quality standards program
Consultant describes how MRI services can meet accreditation deadline
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
Breast MRI and Dense Breasts: A Closer Look at Early Findings from a New Prospective Trial
May 2nd 2024Supplemental breast MRI had a cancer detection rate (CDR) of 20/1000 and a positive predictive value (PPV) of 50 percent, according to preliminary findings from a prospective trial involving women with heterogeneously or very dense breasts.